Cover Image


View/Hide Left Panel

Miettinen TA, Taskinen M-R, Pelkonen R, Nikkila EA. 1969. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand 186:247–253.

Millay RH, Klein ML, Illingworth DR. 1988. Niacin maculopathy. Ophthalmology 95:930–936.

Miller DR, Hayes KC. 1982. Vitamin excess and toxicity. In: Hathcock JN, ed. Nutritional Toxicology, Vol. 1. New York: Academic Press. Pp. 81–133.

Montalto MB, Benson JD, Martinez GA. 1985. Nutrient intake of formula-fed infants and infants fed cow’s milk. Pediatrics 75:343–351.

Morrow JD, Parsons WG 3rd, Roberts LJ 2nd. 1989. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 38:263–274.

Morrow JD, Awad JA, Oates JA, Roberts LJ. 1992. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 98:812–815.

Moss AJ, Levy AS, Kim I, Park YK. 1989. Use of Vitamin and Mineral Supplements in the United States: Current Users, Types of Products, and Nutrients. Advance Data, Vital and Health Statistics of the National Center for Health Statistics, No. 174. Hyattsville, MD: National Center for Health Statistics.

Mrochek JE, Jolley RL, Young DS, Turner WJ. 1976. Metabolic response of humans to ingestion of nicotinic acid and nicotinamide. Clin Chem 22:1821–1827.

Mullin GE, Greenson JK, Mitchel MC. 1989. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med 111:253–255.

NRC (National Research Council). 1989. Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press.

Palumbo PJ. 1991. Rediscovery of crystalline niacin. Mayo Clin Proc 66:112–113.

Pardue WO. 1961. Severe liver dysfunction during nicotinic acid therapy. J Am Med Assoc 175:137–138.

Patterson JI, Brown RR, Linkswiler H, Harper AE. 1980. Excretion of tryptophanniacin metabolites by young men: Effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr 33:2157–2167.

Patterson DJ, Dew EW, Gyorkey R, Graham GY. 1983. Niacin hepatitis. South Med J 76:239–241.

Rader JI, Calvert RJ, Hathcock JN. 1992. Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med 92:77–81.

Ribaya-Mercado JD, Russell RM, Rasmussen HM, Grim MC, Perrone-Petty G, Gershoff SN. 1997. Effect of niacin status on gastrointestinal function and serum lipids. FASEB J 11:A179.

Rivin AU. 1959. Jaundice occurring during nicotinic acid therapy for hypercholesteremia. J Am Med Assoc 170:2088–2089.

Rose DP, Braidman IP. 1971. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr 24:673–683.

Sauberlich HE, Skala JH, Dowdy RP. 1974. Laboratory Tests for the Assessment of Nutritional Status. Boca Raton, FL: CRC Press.

Schwartz ML. 1993. Severe reversible hyperglycemia as a consequence of niacin therapy. Arch Intern Med 153:2050–2052.

Sebrell WH, Butler RE. 1938. A reaction to the oral administration of nicotinic acid. J Am Med Assoc 111:2286–2287.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement